NCT02301572View on ClinicalTrials.gov

Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical Course

CompletedOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions
Multiple Sclerosis
Trial Locations (1)

10021

Weill Cornell Medical College, New York

All Listed Sponsors
collaborator

Genzyme, a Sanofi Company

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER

NCT02301572 - Aggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical Course | Biotech Hunter | Biotech Hunter